Taysha Gene Therapies (TSHA) Income Statement (2019 - 2026)
Income Statement report data from Sep 30, 2019 to Mar 31, 2026 for Taysha Gene Therapies (TSHA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | 5.49M | - | 1.99M (-13.48%) | 2.30M (+13.86%) | 2.02M (+12.85%) | 1.79M (+61.26%) | 1.11M (-67.45%) | 3.41M (-5.28%) | 3.60M (-24.21%) | 4.75M (+97.92%) | 2.40M (-49.04%) | 4.71M (+88.40%) | 2.50M | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 34M (+35.51%) | 25M (-3.11%) | 26M (+27.86%) | 20M (+29.35%) | 16M (+1.57%) | 15M (+2.54%) | 15M (-0.80%) | 15M (-27.06%) | 21M (+62.93%) | 13M (+7.55%) | 12M (-40.42%) | 20M (+58.19%) | 13M (-1.57%) | 13M (-24.21%) | 17M (-28.67%) | 24M (-38.42%) | 38M (+0.69%) | 38M (-4.07%) | 40M (+29.01%) | 31M (+28.47%) | 24M (+94.54%) | 12M (+10.85%) | 11M (+261.44%) | 3.06M | - |
Selling General And Administrative | 9.68M (+9.63%) | 8.83M (+6.64%) | 8.28M (-3.72%) | 8.60M (+5.39%) | 8.16M (+23.08%) | 6.63M (-16.08%) | 7.90M (+7.63%) | 7.34M (+3.67%) | 7.08M (+5.36%) | 6.72M (-21.77%) | 8.59M (+43.41%) | 5.99M (-31.54%) | 8.75M (+19.21%) | 7.34M (-15.44%) | 8.68M (-12.06%) | 9.87M (-13.95%) | 11M (-2.88%) | 12M (+5.92%) | 11M (+10.07%) | 10M (+22.94%) | 8.24M (+34.86%) | 6.11M (+53.52%) | 3.98M (+318.95%) | 950K (+3066.67%) | 30K |
Operating Expenses | 43M (+28.74%) | 34M (-0.71%) | 34M (+18.37%) | 29M (+21.16%) | 24M (+8.06%) | 22M (-20.73%) | 28M (+23.56%) | 22M (-19.21%) | 28M (+39.75%) | 20M (-5.48%) | 21M (-18.54%) | 26M (+21.20%) | 21M (-62.33%) | 56M (+121.80%) | 25M (-23.70%) | 33M (-32.79%) | 50M (-0.14%) | 50M (-1.89%) | 51M (+24.31%) | 41M (+27.05%) | 32M (+74.69%) | 18M (+22.14%) | 15M (+275.06%) | 4.01M (+13266.67%) | 30K |
Depreciation And Amortization | 300K (-16.67%) | 360K (+80.00%) | 200K (-33.33%) | 300K (+7.14%) | 280K (-12.50%) | 320K (+6.67%) | 300K (0.00%) | 300K (-9.09%) | 330K (-2.94%) | 340K (+13.33%) | 300K (-25.00%) | 400K (+21.21%) | 330K (+6.45%) | 310K (+3.33%) | 300K (0.00%) | 300K (+15.38%) | 260K (+44.44%) | 180K (-10.00%) | 200K (+122.22%) | 90K (+200.00%) | 30K (+200.00%) | 10K | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -43.49M (+53.67%) | -28.30M (-16.81%) | -34.02M (+27.18%) | -26.75M (+24.88%) | -21.42M (+7.48%) | -19.93M (-23.05%) | -25.90M (+21.60%) | -21.30M (-12.45%) | -24.33M (+49.72%) | -16.25M (0.00%) | -16.25M (-30.50%) | -23.38M (+41.18%) | -16.56M (-69.32%) | -53.97M (+111.98%) | -25.46M (-23.70%) | -33.37M (-32.79%) | -49.65M (-0.14%) | -49.72M (-1.89%) | -50.68M (+24.31%) | -40.77M (+27.05%) | -32.09M (+74.69%) | -18.37M (+22.14%) | -15.04M (+275.06%) | -4.01M (+13266.67%) | -30.00K |
Ebit | -43.49M (+53.67%) | -28.30M (-16.81%) | -34.02M (+27.18%) | -26.75M (+24.88%) | -21.42M (+7.48%) | -19.93M (-23.05%) | -25.90M (+21.60%) | -21.30M (-12.45%) | -24.33M (+49.72%) | -16.25M (0.00%) | -16.25M (-30.50%) | -23.38M (+41.18%) | -16.56M (-69.32%) | -53.97M (+111.98%) | -25.46M (-23.70%) | -33.37M (-32.79%) | -49.65M (-0.14%) | -49.72M (-1.89%) | -50.68M (+24.31%) | -40.77M (+27.05%) | -32.09M (+74.69%) | -18.37M (+22.14%) | -15.04M (+275.06%) | -4.01M (+13266.67%) | -30.00K |
EBITDA | -43.19M (+54.58%) | -27.94M (-17.39%) | -33.82M (+27.86%) | -26.45M (+25.12%) | -21.14M (+7.80%) | -19.61M (-23.40%) | -25.60M (+21.90%) | -21.00M (-12.50%) | -24.00M (+50.85%) | -15.91M (-0.25%) | -15.95M (-30.59%) | -22.98M (+41.59%) | -16.23M (-69.75%) | -53.65M (+113.24%) | -25.16M (-23.92%) | -33.07M (-33.04%) | -49.39M (-0.32%) | -49.55M (-1.84%) | -50.48M (+24.06%) | -40.69M (+26.92%) | -32.06M (+74.62%) | -18.36M (+22.07%) | -15.04M (+275.06%) | -4.01M (+13266.67%) | -30.00K |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 2.59M (-9.76%) | 2.87M (-9.46%) | 3.17M (+70.43%) | 1.86M (+39.85%) | 1.33M (-21.76%) | 1.70M (-19.43%) | 2.11M (+46.53%) | 1.44M (-14.79%) | 1.69M (-31.30%) | 2.46M (+121.62%) | 1.11M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 10K (0.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (-95.77%) | 710K (-51.70%) | 1.47M (+2.08%) | 1.44M (+5.11%) | 1.37M (+4.58%) | 1.31M (+21.30%) | 1.08M (+45.95%) | 740K (+10.45%) | 670K (-2.90%) | 690K (+27.78%) | 540K (+184.21%) | 190K | - | - | - | - | - |
Net Interest Income | 2.59M (-9.76%) | 2.87M (-9.46%) | 3.17M (+70.43%) | 1.86M (+39.85%) | 1.33M (-24.43%) | 1.76M (-16.59%) | 2.11M (+49.65%) | 1.41M (-15.06%) | 1.66M (-5.14%) | 1.75M | -360.00K (-75.00%) | -1.44M (+5.11%) | -1.37M (+5.38%) | -1.30M (+20.37%) | -1.08M (+45.95%) | -740.00K (+10.45%) | -670.00K (-2.90%) | -690.00K (+27.78%) | -540.00K (+184.21%) | -190.00K | - | - | - | - | - |
Other Non Operating Income | -30.00K (-89.66%) | -290.00K (+625.00%) | -40.00K (-83.33%) | -240.00K | 10K | -110.00K (+37.50%) | -80.00K | 40K | - | -50.00K (+150.00%) | -20.00K | - | -10.00K (-50.00%) | -20.00K | - | - | -670.00K (-46.83%) | -1.26M (+147.06%) | -510.00K (+240.00%) | -150.00K | 70K | -17.01M | - | -17.21M | - |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -42.41M (+52.28%) | -27.85M (-14.91%) | -32.73M (+21.76%) | -26.88M (+24.85%) | -21.53M (+14.64%) | -18.78M (-26.41%) | -25.52M (+21.93%) | -20.93M (-13.01%) | -24.06M | 48M | -117.09M (+375.98%) | -24.60M (+39.61%) | -17.62M (-68.01%) | -55.08M (+107.61%) | -26.53M (-22.18%) | -34.09M (-32.25%) | -50.32M (-0.14%) | -50.39M (-1.56%) | -51.19M (+25.07%) | -40.93M (+27.83%) | -32.02M (+74.78%) | -18.32M (+21.81%) | -15.04M (-29.12%) | -21.22M (+70633.33%) | -30.00K |
Net Income | -42.41M (+52.28%) | -27.85M (-14.91%) | -32.73M (+21.76%) | -26.88M (+24.85%) | -21.53M (+14.64%) | -18.78M (-26.41%) | -25.52M (+21.93%) | -20.93M (-13.01%) | -24.06M | 48M | -117.09M (+375.98%) | -24.60M (+39.61%) | -17.62M (-68.01%) | -55.08M (+107.61%) | -26.53M (-22.18%) | -34.09M (-32.25%) | -50.32M (-0.14%) | -50.39M (-1.56%) | -51.19M (+25.07%) | -40.93M (+27.83%) | -32.02M (+74.78%) | -18.32M (+21.81%) | -15.04M (-29.12%) | -21.22M (+70633.33%) | -30.00K |
Comprehensive Income Net Of Tax | -41.23M (-60.79%) | -105.16M (+216.94%) | -33.18M (+31.20%) | -25.29M (+27.86%) | -19.78M (-78.81%) | -93.33M (+208.43%) | -30.26M (+65.63%) | -18.27M (-24.85%) | -24.31M (-78.21%) | -111.57M (-4.71%) | -117.09M (+375.98%) | -24.60M (+39.61%) | -17.62M | - | - | - | - | - | - | - | - | - | - | - | - |